Multicenter study of endocrine function and plasma lipids and lipoproteins in women using oral contraceptives containing desogestrel progestin
- 30 April 1997
- journal article
- Published by Elsevier in Contraception
- Vol. 55 (4) , 219-224
- https://doi.org/10.1016/s0010-7824(97)00010-3
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Twelve years of clinical experience with an oral contraceptive containing 30μg ethinyloestradiol and 150μg desogestrelContraception, 1995
- Influence of oral contraceptives on integrated secretion of gonadotropinsContraception, 1992
- A multicenter efficacy and safety study of an oral contraceptive containing 150 μg desogestrel and 30 μg ethinyl estradiolContraception, 1992
- Oral contraceptives and coronary heart disease: Modulation of glucose tolerance and plasma lipid risk factors by progestinsAmerican Journal of Obstetrics and Gynecology, 1988
- The effect of oral contraceptives on plasma-free and salivary cortisol and cortisoneClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levelsContraception, 1985
- Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrelContraception, 1983
- Oral Contraceptives and Cardiovascular DiseaseNew England Journal of Medicine, 1981
- Thromboembolic Disease and the Steroidal Content of Oral Contraceptives. A Report to the Committee on Safety of DrugsBMJ, 1970
- Effect of an Ovulatory Suppressant on the Serum Protein-Bound Iodine and the Red-Cell Uptake of Radioactive TrimodothyronineNew England Journal of Medicine, 1963